Skip to main content
Clinical Trials/NCT03414827
NCT03414827
Recruiting
Not Applicable

Genetic Evaluation of Renal Cell Carcinoma; Predicting Biomarkers for Renal Cell Carcinoma

Zealand University Hospital1 site in 1 country120 target enrollmentFebruary 1, 2019
ConditionsKidney Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Kidney Cancer
Sponsor
Zealand University Hospital
Enrollment
120
Locations
1
Primary Endpoint
DNA
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Recruitment of participants to the study takes place at the urological department at Zealand University Hospital, Roskilde, Feb. 2018-April 2018. 10 people with diagnosis of renal cancer should be recruited in phases 1. Subsequently, biological materials from 100 patients with kidney cancer will be used from the national Biobank. In phase 3, 10 patients will be recruited for the final gene test.

Registry
clinicaltrials.gov
Start Date
February 1, 2019
End Date
December 1, 2027
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Nessn Azawi

Clinical Professor

Zealand University Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients who have been diagnosed with kidney cancer.

Exclusion Criteria

  • Patients without signs of malignancy at final histology report.
  • Incapacitated patients.

Outcomes

Primary Outcomes

DNA

Time Frame: 30 days

Sequence variation in specific genes

Study Sites (1)

Loading locations...

Similar Trials